News
Douglass Hanly Moir Pathology recognises we have an important role to play in supporting our clinicians and their patients by providing current information and the latest updates regarding pathology testing.
Prostate specific antigen (PSA) testing – New conditions apply
Wednesday, 01 November 2023
From 1 November 2023, conditions have changed for PSA items in the Medicare Benefits Schedule (MBS) which affect the frequency of PSA assessment and the performance of follow-up testing that will be eligible for a Medicare rebate.
Reproductive carrier screening (RCS) – New Medicare rebates
Wednesday, 01 November 2023
From 1 November 2023, Medicare rebates apply to reproductive carrier screening, covering cystic fibrosis (CF), spinal muscular atrophy (SMA) and fragile X syndrome (FXS).